Author: Ahn, Jin Young; Sohn, Yujin; Lee, Su Hwan; Cho, Yunsuk; Hyun, Jong Hoon; Baek, Yae Jee; Jeong, Su Jin; Kim, Jung Ho; Ku, Nam Su; Yeom, Joon-Sup; Roh, Juhye; Ahn, Mi Young; Chin, Bum Sik; Kim, Young Sam; Lee, Hyukmin; Yong, Dongeun; Kim, Hyun Ok; Kim, Sinyoung; Choi, Jun Yong
Title: Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea Document date: 2020_4_6
ID: 1uwir5b8_14
Snippet: Intravenous methylprednisolone was started just before the convalescent plasma infusion in both cases. We did not use corticosteroids from the beginning as a routine treatment. Current guidelines recommend that systemic corticosteroids should not be given routinely for the treatment of COVID-19 due to the lack of evidence of its clinical efficacy on mortality reduction. 7,8 However, we decided to start corticosteroids when the patients' condition.....
Document: Intravenous methylprednisolone was started just before the convalescent plasma infusion in both cases. We did not use corticosteroids from the beginning as a routine treatment. Current guidelines recommend that systemic corticosteroids should not be given routinely for the treatment of COVID-19 due to the lack of evidence of its clinical efficacy on mortality reduction. 7,8 However, we decided to start corticosteroids when the patients' condition rapidly deteriorated to ARDS. Methylprednisolone was administered one day and two days before the plasma infusion in case 1 and case 2, respectively. Serial laboratory and oxygenation parameters showed rapid improvement right after the corticosteroid administration even before the convalescent plasma infusion.
Search related documents:
Co phrase search for related documents- case convalescent plasma infusion and convalescent plasma infusion: 1
- case convalescent plasma infusion and plasma infusion: 1
- clinical efficacy and convalescent plasma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- clinical efficacy and convalescent plasma infusion: 1, 2, 3
- clinical efficacy and corticosteroid administration: 1
- clinical efficacy and current guideline: 1
- clinical efficacy and intravenous methylprednisolone: 1
- clinical efficacy and mortality reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- clinical efficacy and mortality reduction clinical efficacy: 1
- clinical efficacy and oxygenation parameter: 1
- clinical efficacy and patient condition: 1, 2, 3, 4
- clinical efficacy and plasma infusion: 1, 2, 3, 4
- clinical efficacy and rapid improvement: 1
- clinical efficacy and routine treatment: 1, 2, 3, 4, 5, 6, 7, 8
- clinical efficacy and systemic corticosteroid: 1, 2
- convalescent plasma and intravenous methylprednisolone: 1, 2, 3, 4, 5
- convalescent plasma and mortality reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
- convalescent plasma and patient condition: 1, 2, 3, 4, 5
- convalescent plasma and plasma infusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
Co phrase search for related documents, hyperlinks ordered by date